Author

B. Dogan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1

Frequent Co-Authors

S. Durdagi· 3 shared A. B. Peksen· 1 shared A. Barty· 1 shared A. Batyuk· 1 shared A. D. Yucel· 1 shared A. M. Rothemich· 1 shared A. Olkan· 1 shared A. Rogala· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiophysics

S. Durdagi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

DIFFERENTIAL SCANNING CALORIMETRY: A SUITABLE METHODOLOGY TO PROBLEM THE BINDING PROPERTIES OF BCL-2 INHIBITORS

B. Dinc, B. Dogan, T. Mavromoustakos, S. Durdagi

This study evaluates the binding constants of nine BCL-2 inhibitors using DSC, showing agreement with prior biological assays and simulations, and suggests DSC's utility in high-throughput drug screening.

bioRxiv · Oct 7, 2023 · PreprintBiophysics

Investigating the Effect of GLU283 Protonation State on the Conformational Heterogeneity of CCR5 by Molecular Dynamics Simulations

B. Dogan, S. Durdagi

This study uses molecular dynamics simulations to show that the protonation state of GLU2837.39 in CCR5 affects its conformational changes when bound to GP120 or MRV.

bioRxiv · Aug 17, 2023Biophysics

Near-Physiological-Temperature Serial Femtosecond X-ray Crystallography Reveals Novel Conformations of SARS-CoV-2 Main Protease Active Site for Improved Drug Repurposing

S. Durdagi, C. Dag, B. Dogan, M. Yigin, T. Avsar, C. Buyukdag, I. Erol, F. B. Ertem, S. Calis, G. Yildirim, M. Orhan, O. Guven, B. Aksoydan, E. Destan, K. Sahin, , Sn

The paper determines two apo structures of SARS-CoV-2 main protease at near-physiological temperature using SFX and uses molecular simulations to analyze inhibitor binding for drug repurposing.

bioRxiv · Sep 9, 2020Biophysics

Yersiniabactin producing AIEC promote inflammation-associated fibrosis in gnotobiotic Il10-/- mice

M. Ellermann, R. Gharaibeh, L. Fulbright, B. Dogan, L. N. Moore, C. A. Broberg, L. R. Lopez, A. M. Rothemich, J. Herzog, A. Rogala, I. O. Gordon, F. Rieder, C. R. Brouwer, K. W. Simpson, C. Jobin, , J. C. Arthur

The paper shows that Yersiniabactin-producing AIEC bacteria cause inflammation-associated fibrosis in mice, with Ybt import receptor FyuA influencing fibrosis severity.

bioRxiv · Aug 2, 2019Microbiology